ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,431.60
-0.04%
Dow Jones
38,589.16
-0.15%
US Dollar vs MXN
18.4648
0.00%
Brent Oil
82.125
-0.18%
Bitcoin
66,639.00
0.68%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Melinta Therapeutics Inc (MLNT)

  7. Melinta Therapeutics Inc (MLNT) Noticias

MLNT

Melinta Therapeutics (MLNT)

Melinta Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:MLNT
FechaHoraFuenteTítuloSímboloCompañía
24/06/202015:02GlobeNewswire Inc.Melinta Therapeutics Announces Termination of Merger Agreement and Tender Offer for Shares of TetraphaseNASDAQ:MLNTMelinta Therapeutics Inc
09/06/202015:02GlobeNewswire Inc.Melinta Therapeutics Enters Into Agreement to Acquire Tetraphase PharmaceuticalsNASDAQ:MLNTMelinta Therapeutics Inc
04/03/202015:03GlobeNewswire Inc.Melinta Therapeutics Confirms Deerfield as Successful Bidder for CompanyNASDAQ:MLNTMelinta Therapeutics Inc
13/02/202015:02GlobeNewswire Inc.Melinta Therapeutics Announces Court Approval of Chapter 11 Bidding ProceduresNASDAQ:MLNTMelinta Therapeutics Inc
05/02/202010:15Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:MLNTMelinta Therapeutics Inc
08/01/202015:39Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNTMelinta Therapeutics Inc
27/12/201908:02GlobeNewswire Inc.Melinta Therapeutics Announces Restructuring Support Agreement with its Secured Lenders under its Senior Credit FacilityNASDAQ:MLNTMelinta Therapeutics Inc
12/11/201916:07GlobeNewswire Inc.Melinta Therapeutics Files Quarterly Report on Form 10-Q for the Quarter Ended September 30, 2019NASDAQ:MLNTMelinta Therapeutics Inc
12/11/201916:00Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MLNTMelinta Therapeutics Inc
25/10/201911:54Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:MLNTMelinta Therapeutics Inc
24/10/201915:02GlobeNewswire Inc.Melinta Therapeutics Announces U.S. FDA Approval of Supplemental New Drug Application for BAXDELA® (delafloxacin) for the Tr...NASDAQ:MLNTMelinta Therapeutics Inc
01/10/201909:07PR Newswire (US)Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2019NASDAQ:MLNTMelinta Therapeutics Inc
03/09/201915:05GlobeNewswire Inc.Melinta Therapeutics Announces Appointment of Jennifer Sanfilippo to Interim Chief Executive Officer and DirectorNASDAQ:MLNTMelinta Therapeutics Inc
13/08/201905:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MLNTMelinta Therapeutics Inc
09/08/201906:31GlobeNewswire Inc.Melinta Therapeutics Names David Gill as Chairman and Announces CEO Succession PlanNASDAQ:MLNTMelinta Therapeutics Inc
09/08/201906:30GlobeNewswire Inc.Melinta Therapeutics Reports Second Quarter 2019 Financial Results and Provides Business UpdateNASDAQ:MLNTMelinta Therapeutics Inc
06/08/201916:04GlobeNewswire Inc.Melinta Therapeutics Announces Rescheduling of Second Quarter 2019 Financial Results ReportingNASDAQ:MLNTMelinta Therapeutics Inc
16/07/201906:30GlobeNewswire Inc.Melinta Therapeutics Announces Preliminary Second Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:MLNTMelinta Therapeutics Inc
10/07/201914:00Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MLNTMelinta Therapeutics Inc
01/07/201908:13PR Newswire (US)X-Biotix Therapeutics Joins Antimicrobials Working GroupNASDAQ:MLNTMelinta Therapeutics Inc
26/06/201915:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MLNTMelinta Therapeutics Inc
20/06/201910:13PR Newswire (US)Antimicrobials Working Group Highlights Member Company Participation at ASM Microbe 2019NASDAQ:MLNTMelinta Therapeutics Inc
19/06/201906:30GlobeNewswire Inc.Melinta Therapeutics Announces U.S. FDA Acceptance of Supplemental New Drug Application for BAXDELA® (delafloxacin) for the ...NASDAQ:MLNTMelinta Therapeutics Inc
07/06/201908:27PR Newswire (US)Antimicrobials Working Group Commends Senator Isakson and Senator Casey for Introducing Legislation to Improve Access to Inno...NASDAQ:MLNTMelinta Therapeutics Inc
16/05/201916:31Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:MLNTMelinta Therapeutics Inc
09/05/201915:00GlobeNewswire Inc.Melinta Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:MLNTMelinta Therapeutics Inc
07/05/201906:30GlobeNewswire Inc.Melinta Therapeutics to Present at Making a Difference in Infectious Diseases (MAD-ID) 2019 Annual MeetingNASDAQ:MLNTMelinta Therapeutics Inc
02/05/201915:30GlobeNewswire Inc.Melinta Therapeutics to Report First Quarter 2019 Financial Results on May 9, 2019NASDAQ:MLNTMelinta Therapeutics Inc
30/04/201905:18Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:MLNTMelinta Therapeutics Inc
12/04/201909:08PR Newswire (US)Antimicrobials Working Group Highlights Member Company Participation at the 29th European Congress of Clinical Microbiology a...NASDAQ:MLNTMelinta Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:MLNT

Su Consulta Reciente

AMEX
XLF
Financial Select Sector
USOTC
RHHBY
Roche (QX)
AMEX
XLV
Health Care Select Sector
COIN
ETHUSD
Ethereum
PM
XAUUSD
Gold vs US Dollar
CCOM
OILBRENT
Brent Oil
CCOM
US500
US 500
USOTC
BASFY
BASF (QX)
FX
USDMXN
US Dollar vs MXN
FX
EURMXN
Euro vs MXN
NYSE
DIS
Walt Disney
NYSE
NKE
Nike
SPI
SP500
S&P 500
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
AXP
American Express
NYSE
BAC
Bank of America
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados